Latest Content

Novel Therapy Shows Promise in Liver Cancer Subset, May Address ‘Urgent Need for New Therapies’

January 21st 2021, 7:00pm

By Ryan McDonald

Article

“Along with a tolerable safety profile and supportive quality of life, these final efficacy results demonstrate the clinical benefit of (Tibsovo) in (previously treated patients with IDH1-mutant cholangiocarcinoma), for which there is an urgent need for new therapies,” said an expert from Massachusetts General Hospital, who presented the data.

Marking An Anniversary Cancer Survivors Never Wanted

January 21st 2021, 5:00pm

By Bill Ramshaw

Article

It's important for cancer survivors to recognize the major milestones and anniversaries in their cancer journey. Even if it's an anniversary they didn't want.

Identifying and Addressing the Barriers to Clinical Trial Access

January 21st 2021, 4:00pm

By Jessica Skarzynski

Podcast

This week on the “CURE® Talks Cancer” podcast, we spoke with Martha Raymond, of The Raymond Foundation, about how providers can ensure patient safety to increase trial enrollment during the COVID-19 pandemic, and what she and her colleagues are doing to provide better trial access to all patients with cancer.

Bavencio Shows No Improvement of Overall Survival for Patients with Gastric Cancers

January 21st 2021, 2:00pm

By Colleen Moretti

Article

For patients with gastric/ gastroesophageal cancer, treatment with Bavencio after chemotherapy shows favorable safety, but no overall survival improvement.

Clinical Trials Can Be Scary – But with Advice From Past Participants, They Don’t Have To Be

January 20th 2021, 10:00pm

By Jessica Skarzynski

Video

Clinical trials may seem scary and challenging for patients with cancer, but in reality, they don’t have to be. Here is how talking to former patients on clinical trials can help.

Real-World Patients May Have More Side Effects to Immunotherapy for Lung Cancer Compared With Clinical Trial Data

January 20th 2021, 7:00pm

By Darlene Dobkowski, MA

Article

Findings from a study focused on patient-reported experiences, found that aching joints, aching muscles and fatigue were more common than initially found in clinical trials.

Appointment Fatigue is a Real Thing And Here’s How to Manage It

January 20th 2021, 5:00pm

By Ron Cooper

Article

Appointment fatigue is a real thing for patients with cancer and even survivors, but there are ways to overcome it.

FDA Grants Priority Review for Opdivo for Several Gastrointestinal Cancers

January 20th 2021, 4:00pm

By Darlene Dobkowski, MA

Article

The priority review will focus on Opdivo with chemotherapy for the treatment several gastrointestinal cancers, which has recently become a rising area in novel treatment development.

Inlyta-Synthetic Hormone Combo Fails to Significantly Improve Survival Outcome in Pancreatic Neuroendocrine Tumors

January 20th 2021, 2:00pm

By Ryan McDonald

Article

The combination of Inlyta (axitinib) and the synthetic hormone octreotide acetate failed to significantly improve progression-free survival, compared to placebo with the synthetic hormone. However, the results indicated the Inlyta-based combination did improve disease response in patients versus the placebo-based combination.

Avastin-Lonsurf Combo Improves Survival in Patients with Metastatic Colorectal Cancer Ineligible for Standard Chemo

January 19th 2021, 10:00pm

By Ryan McDonald

Article

In the final analysis of the phase 2 TASCO1 trial, patients within the Lonsurf and Avastin arm reached a median overall survival of 22.31 months compared with 17.67 months in the Xeloda and Avastin arm.

Tecentriq-Avastin Combo Continues to Show Improved Survival Benefit in Patients with Advanced Liver Cancer

January 19th 2021, 7:00pm

By Ryan McDonald

Article

“This is the longest survival seen in a phase 3 study of advanced liver cancer,” lead study author Dr. Richard S. Finn, of the UCLA Jonsson Comprehensive Cancer Center, said in a virtual presentation of the data.

The Balancing Act of Being a Cancer Caregiver and Parent

January 19th 2021, 5:00pm

By Debbie Legault

Article

The balancing act of being a caregiver and parent simultaneously is one that requires acceptance and fierceness.

Advanced-Stage Rare Type of Gastrointestinal Cancer More Common in Men, Associated with ‘Excellent’ 5-Year Survival Rates

January 19th 2021, 4:00pm

By Ryan McDonald

Article

The data in the study presented at the ASCO Gastrointestinal Cancers Symposium demonstrated that while rare, stage 4 gastrointestinal stromal tumors often spread to the liver.

Learning the Basics of a Rare Disease: Cutaneous T-Cell Lymphoma

January 19th 2021, 2:00pm

By Kristie L. Kahl

Video

On behalf of the Cutaneous Lymphoma Foundation, CURE spoke with Drs. Steven M. Horwitz and Lauren Pinter-Brown about the basics of cutaneous T-cell lymphoma, as well as current treatment options and those being evaluated for the rare disease.

Novel Artificial Intelligence Tool May Help Patients with Cancer Find, Understand Clinical Trials

January 18th 2021, 10:00pm

By Ryan McDonald

Article

A group of patients with gastrointestinal cancers reported that a novel artificial intelligence-based search tool made it easier for them to find and understand cancer clinical trials. The tool, according to study authors, would not only help with trial accrual, but could also help improve trial diversity.